The neurotoxin MPTP, used in PD models, is converted to MPP+ in astrocytes, activating the NF‐κB/JNK/c‐Jun pathway to downregulate glutamate transporter‐1 (GLT‐1), thereby reducing glutamate uptake and causing excitotoxicity. This evidence concerns the gene SLC1A2 and Parkinson disease.